000 | 01217 a2200385 4500 | ||
---|---|---|---|
005 | 20250513201530.0 | ||
264 | 0 | _c20000127 | |
008 | 200001s 0 0 eng d | ||
022 | _a0028-3878 | ||
024 | 7 |
_a10.1212/wnl.54.1.244 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPal, P K | |
245 | 0 | 0 |
_aBotulinum toxin A as treatment for drooling saliva in PD. _h[electronic resource] |
260 |
_bNeurology _cJan 2000 |
||
300 |
_a244-7 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aBotulinum Toxins, Type A _xtherapeutic use |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInjections |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aParkinson Disease _xcomplications |
650 | 0 | 4 |
_aParotid Gland _xdrug effects |
650 | 0 | 4 |
_aSaliva _xdrug effects |
650 | 0 | 4 |
_aSialorrhea _xdrug therapy |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aCalne, D B | |
700 | 1 | _aCalne, S | |
700 | 1 | _aTsui, J K | |
773 | 0 |
_tNeurology _gvol. 54 _gno. 1 _gp. 244-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1212/wnl.54.1.244 _zAvailable from publisher's website |
999 |
_c10591494 _d10591494 |